F
Federica Facciotti
Researcher at European Institute of Oncology
Publications - 77
Citations - 2851
Federica Facciotti is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Medicine & Immune system. The author has an hindex of 23, co-authored 55 publications receiving 1741 citations. Previous affiliations of Federica Facciotti include University Hospital of Basel & University of Zurich.
Papers
More filters
Journal ArticleDOI
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses.
Giulia Nizzoli,Jana Krietsch,Anja Weick,Svenja Steinfelder,Federica Facciotti,Paola Gruarin,Annalisa Bianco,Bodo Steckel,Monica Moro,Mariacristina Crosti,Chiara Romagnani,K Stölzel,Sara Torretta,Lorenzo Pignataro,Carmen Scheibenbogen,Petra Neddermann,Raffaele De Francesco,Sergio Abrignani,Jens Geginat +18 more
TL;DR: CD1c(+)mDC1 are the relevant source of IL-12 for naive T cells and are fully equipped to cross-prime cytotoxic T-cell responses.
Journal ArticleDOI
Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus
Federica Facciotti,Federica Facciotti,G.S. Ramanjaneyulu,Marco Lepore,Sebastiano Sansano,Marco Cavallari,Magdalena Kistowska,Magdalena Kistowska,Sonja Forss-Petter,Guanghui Ni,Alessia Colone,Amit Singhal,Johannes Berger,Chengfeng Xia,Lucia Mori,Lucia Mori,Gennaro De Libero,Gennaro De Libero +17 more
TL;DR: Mice deficient in the peroxisomal enzyme glyceronephosphate O-acyltransferase (GNPAT), essential for the synthesis of ether lipids, had significant alteration of the thymic maturation of iNKT cells and fewer iNKK cells in both thymus and peripheral organs, which confirmed the role of ether-bonded lipids as iN KT cell antigens.
Journal ArticleDOI
Baricitinib restrains the immune dysregulation in patients with severe COVID-19.
Vincenzo Bronte,Stefano Ugel,Elisa Tinazzi,Antonio Vella,Francesco De Sanctis,Stefania Canè,Veronica Batani,Rosalinda Trovato,Alessandra Fiore,Varvara Petrova,Francesca Hofer,Roza Maria Barouni,Chiara Musiu,Simone Caligola,Laura Pinton,Lorena Torroni,Enrico Polati,Katia Donadello,Simonetta Friso,Francesca Pizzolo,Manuela Iezzi,Federica Facciotti,Pier Giuseppe Pelicci,Daniela Righetti,Paolo Bazzoni,Mariaelisa Rampudda,Andrea Claudio Comel,Walter Mosaner,Claudio Lunardi,Oliviero Olivieri +29 more
TL;DR: Baricitinib prevented the progression towards a severe/extreme form of the viral disease by modulating the patients' immune landscape and these changes were associated with a safer and favorable clinical outcome of patients with COVID-19 pneumonia.
Journal ArticleDOI
Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells.
Claudia Burrello,Claudia Burrello,Federica Garavaglia,Fulvia Milena Cribiù,Giulia Ercoli,Gianluca Lopez,Jacopo Troisi,Angelo Colucci,Silvia Guglietta,Sara Carloni,Simone Guglielmetti,Valentina Taverniti,Giulia Nizzoli,Silvano Bosari,Flavio Caprioli,Flavio Caprioli,Maria Rescigno,Federica Facciotti +17 more
TL;DR: It is shown that therapeutic FMT reduces colonic inflammation and initiates the restoration of intestinal homeostasis through the simultaneous activation of different immune-mediated pathways, ultimately leading to IL-10 production by innate and adaptive immune cells and reduces the ability of dendritic cells, monocytes and macrophages to present MHCII-dependent bacterial antigens to colonic T cells.
Journal ArticleDOI
Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes.
Chiara Sorini,Ilaria Cosorich,Marta Lo Conte,Lorena De Giorgi,Federica Facciotti,Roberta Lucianò,Martina Rocchi,Roberto Ferrarese,Francesca Sanvito,Filippo Canducci,Marika Falcone +10 more
TL;DR: The results indicate that loss of gut barrier continuity can lead to activation of islet-specific T cells within the intestinal mucosa and to autoimmune diabetes and provide a strong rationale to design innovative therapeutic interventions in “at-risk” individuals aimed at restoring gut barrier integrity to prevent T1D occurrence.